Literature DB >> 23621588

Fungal diagnosis: how do we do it and can we do better?

John R Perfect1.   

Abstract

BACKGROUND: Morbidity and mortality remain high for patients with invasive fungal infections (IFIs) despite an increasing number of antifungals and other treatments. Many studies indicate that delayed or inaccurate diagnosis and treatment are major causes of poor outcomes in patients with IFIs.
OBJECTIVE: The aim of the current paper is to provide a review of traditional and newer approaches to the diagnosis of IFIs, with a particular focus on invasive candidiasis (IC) and aspergillosis (IA). Recent studies from the author's institution are highlighted, along with an advancement in cryptococcal meningitis diagnosis that should improve the care of AIDS and its opportunistic infection in many developing countries.
FINDINGS: Currently available tools for the diagnosis of IFIs include traditional methods like histopathology, culture, and radiology, and newer antigen- and PCR-based diagnostic assays. Attempts have also been made to predict IFIs based on colonization or other factors, including genetic polymorphisms impacting IFI susceptibility in high-risk patients. Biopsy with histopathologic analysis is often not possible in patients suspected of pulmonary aspergillosis due to increased bleeding risk, and blood cultures for IC, IA, or other IFIs are hindered by poor sensitivity and slow turnaround time which delays diagnosis. Radiology is often used to predict IFI but suffers from inability to differentiate certain pathogens and does not generally provide certainty of IFI diagnosis. Newer antigen-based diagnostics for early diagnosis include the β-glucan assay for IFIs, galactomannan assay for IA, and a recent variation on the traditional cryptococcal antigen (CRAG) test with a Lateral Flow Assay for invasive cryptococcosis. PCR-based diagnostics represent additional tools with high sensitivity for the rapid diagnosis of IFIs, although better standardization of these methods is still required for their routine clinical use.
CONCLUSION: Better understanding of the strengths and weaknesses of currently available diagnostic tools, and further devising linked strategies to best implement them either alone or in combination, would greatly improve early and accurate diagnosis of IFIs and improve their successful management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621588     DOI: 10.1185/03007995.2012.761134

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  27 in total

1.  Fungal infections of the central nervous system.

Authors:  Claire S Jacobs; Mark R Etherton; Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

2.  Detection of multiple fungal species in blood samples by real-time PCR: an interpretative challenge.

Authors:  Catriona L Halliday; Tania C Sorrell; Sharon C-A Chen
Journal:  J Clin Microbiol       Date:  2014-09       Impact factor: 5.948

Review 3.  Cryptococcosis diagnosis and treatment: What do we know now.

Authors:  John R Perfect; Tihana Bicanic
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

4.  Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.

Authors:  Gemma L Johnson; Shah-Jalal Sarker; Francesco Nannini; Arianna Ferrini; Emma Taylor; Cornelia Lass-Flörl; Wolfgang Mutschlechner; Stephen A Bustin; Samir G Agrawal
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

5.  Comprehensive Evaluation of Compendial USP<71>, BacT/Alert Dual-T, and Bactec FX for Detection of Product Sterility Testing Contaminants.

Authors:  Matthew R England; Frida Stock; James E T Gebo; Karen M Frank; Anna F Lau
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

6.  Small-molecule inhibitors for the Prp8 intein as antifungal agents.

Authors:  Zhong Li; Anil Mathew Tharappel; Jimin Xu; Yuekun Lang; Cathleen M Green; Jing Zhang; Qishan Lin; Sudha Chaturvedi; Jia Zhou; Marlene Belfort; Hongmin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

7.  Cryptococcal osteomyelitis in an adolescent survivor of T-cell acute lymphoblastic leukemia.

Authors:  Djin-Ye Oh; P Pallavi Madhusoodhan; Deborah J Springer; Kenneth Inglima; Ali A Chaudhri; Joseph Heitman; Elizabeth A Raetz; Alka Khaitan; Mona Rigaud
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

8.  (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections.

Authors:  Anurag N Malani; Bonita Singal; L Joseph Wheat; Ola Al Sous; Theresa A Summons; Michelle M Durkin; April C Pettit
Journal:  J Clin Microbiol       Date:  2014-12-24       Impact factor: 5.948

Review 9.  Equine Pulmonary Cryptococcosis: A Comparative Literature Review and Evaluation of Fluconazole Monotherapy.

Authors:  C J Secombe; G D Lester; M B Krockenberger
Journal:  Mycopathologia       Date:  2016-09-21       Impact factor: 2.574

10.  Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients.

Authors:  H Teixeira; L Silva; J J F Magalhães; C Matias; J F F Magalhães; J M A Lyra; V Magalhães; N Lucena-Silva; H R L Melo; M B Jucá; C A A Brito
Journal:  Support Care Cancer       Date:  2014-06-05       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.